CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 39 enrolled
Drug / intervention
Pregabalin +1 moredrug
Likely dose
Pregabalin 75mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00908375
NCT00908375Phase 4Completed

Efficacy of Pregabalin in Patients With Radicular Pain

Northwestern University·interventional·Posted May 25, 2009·Updated Oct 13, 2014

In Brief

A Phase 4 clinical trial evaluating Pregabalin and Sugar Pill for Neuropathy; Radicular, Lumbar, Lumbosacral and 3 related conditions. Completed, enrolled 39 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate whether pregabalin is effective in reducing the pain in patients who present with radicular pain due to a herniated disc, spinal stenosis or failed back surgery syndrome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 25, 2009
Enrollment StartMay 1, 2009
Primary CompletionSep 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 17.1 years ago

Interventions

Pregabalindrug

One pregabalin 75mg capsule will be prescribed twice daily for the first week of the study (150mg/day). For the subsequent 2 weeks, the dose will be increased to 2 pregabalin capsules twice a day (300mg/day). The total duration of the treatment will be 3 weeks.

Sugar Pilldrug

One sugar pill will be prescribed twice daily for the first week of the study. For the subsequent 2 weeks, 2 placebo(sugar pills) capsules twice a day. The total duration of the treatment will be 3 weeks.